@prefix dct: .
@prefix orcid: .
@prefix this: .
@prefix rdfs: .
@prefix xsd: .
@prefix sio: .
@prefix ncit: .
@prefix lld: .
@prefix miriam-gene: .
@prefix miriam-pubmed: .
@prefix eco: .
@prefix wi: .
@prefix prov: .
@prefix pav: .
@prefix prv: .
@prefix np: .
@prefix dgn-np: .
@prefix dgn-gda: .
@prefix dgn-void: .
dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_head {
this: np:hasAssertion dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_assertion;
np:hasProvenance dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_provenance;
np:hasPublicationInfo dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_publicationInfo;
a np:Nanopublication .
dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_assertion a np:Assertion .
dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_provenance a np:Provenance .
dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_publicationInfo a
np:PublicationInfo .
}
dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_assertion {
miriam-gene:2147 a ncit:C16612 .
lld:C0149871 a ncit:C7057 .
dgn-gda:DGNf1ecf6dda8e6748ef71f874652687e86 sio:SIO_000628 miriam-gene:2147, lld:C0149871;
a sio:SIO_001122 .
}
dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_provenance {
dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_assertion dct:description
"[As gene variants predisposing to thrombophilia and influencing the increased risk of vein thrombosis might influence response to local thrombolysis, the aim of the work was to characterize the pharmacogenetic conditions for local streptokinase treatment in patients with a deep vein thrombosis (DVT) of lower extremities based on the following polymorphism analyses: G1691A polymorphism of factor V (FV), G20210A polymorphism of prothrombin (PT), A4250G (Thr312Ala) polymorphism of fibrinogen-alpha (FGA), G(-455)A polymorphism of fibrinogen-beta (FGB), 4G/5G polymorphism of plasminogen activator inhibitor type 1(PAI-1) and insertion/deletion (I/D) polymorphism of tissue plasminogen activator (t-PA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en;
wi:evidence dgn-void:source_evidence_literature;
sio:SIO_000772 miriam-pubmed:16466010;
prov:wasDerivedFrom dgn-void:gad-20130706;
prov:wasGeneratedBy eco:ECO_0000203 .
dgn-void:gad-20130706 pav:importedOn "2013-07-06"^^xsd:date .
dgn-void:source_evidence_literature a eco:ECO_0000212;
rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en;
rdfs:label "DisGeNET evidence - LITERATURE"@en .
}
dgn-np:NP44561.RAsKxbomuGxBq1yzy6Tcy_gqP6frU0kaykweem9Vf-nxk130_publicationInfo {
this: dct:created "2014-10-02T12:32:20+02:00"^^xsd:dateTime;
dct:rights ;
dct:rightsHolder dgn-void:IBIGroup;
dct:subject sio:SIO_000983;
prv:usedData dgn-void:disgenetrdf;
pav:authoredBy orcid:0000-0001-5999-6269, orcid:0000-0002-7534-7661, orcid:0000-0002-9383-528X,
orcid:0000-0003-0169-8159, orcid:0000-0003-1244-7654;
pav:createdBy orcid:0000-0003-0169-8159;
pav:version "v2.1.0.0" .
dgn-void:disgenetrdf pav:version "v2.1.0" .
}